Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.47 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.47 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | AHR | P35869 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 3/20 | 0.43 |
| ▸ | HTR2C | P28335 | 3/20 | 0.43 |
| ▸ | HTR2B | P41595 | 2/20 | 0.43 |
| ▸ | HTR1D | P28221 | 2/20 | 0.43 |
| ▸ | HTR1B | P28222 | 2/20 | 0.43 |
| ▸ | HTR7 | P34969 | 2/20 | 0.43 |
| ▸ | HTR6 | P50406 | 2/20 | 0.43 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6535531 | 0.87 | SLC22A6 (0.58) | SLC22A6ATMNR4A2CREBBPPBRM1 | |
| SCHEMBL1899742 | 0.83 | SLC22A6 (0.59) | SLC22A6ATMNR4A2CREBBPPBRM1 | |
| SCHEMBL3538344 | 0.79 | SLC22A6 (0.58) | SLC22A6ATMNR4A2CREBBPPBRM1 | |
| SCHEMBL31378042 | 0.76 | SLC22A6 (0.61) | SLC22A6ATMNR4A2CREBBPPBRM1 | |
| SCHEMBL28374800 | 0.75 | SLC22A6 (0.55) | SLC22A6ATMNR4A2CREBBPPBRM1 | |
| SCHEMBL28459212 | 0.75 | SLC22A6 (0.59) | SLC22A6ATMNR4A2CREBBPPBRM1 | |
| SCHEMBL28961088 | 0.75 | SLC22A6 (0.55) | SLC22A6ATMNR4A2PBRM1GPR84 | |
| SCHEMBL1198963 | 0.74 | SLC22A6 (0.54) | SLC22A6ATMNR4A2CREBBPPBRM1 | |
| SCHEMBL5229462 | 0.74 | SLC22A6 (0.54) | SLC22A6ATMGPR84CYP3A4MEN1 | |
| SCHEMBL21965348 | 0.74 | SLC22A6 (0.54) | SLC22A6ATMNR4A2CREBBPPBRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3494093-B1 | METHODS AND USES OF DISSOLVED ORGANIC MATERIAL FRACTIONS FOR BINDING METAL IONS | NOBLEGEN INC (CA) | 2022-05-18 | — | — | EP | claimed |
| US-10773978-B2 | Methods and uses of dissolved organic material fractions for binding metal ions | Noblegen, Inc. (CA) | 2020-09-15 | — | — | US | claimed |
| US-20190210898-A1 | METHODS AND USES OF DISSOLVED ORGANIC MATERIAL FRACTIONS FOR BINDING METAL IONS | TRENT UNIVERSITY (CA) | 2019-07-11 | — | — | US | claimed |
| EP-3494093-A1 | METHODS AND USES OF DISSOLVED ORGANIC MATERIAL FRACTIONS FOR BINDING METAL IONS | Noblegen Inc. (CA) | 2019-06-12 | — | — | EP | claimed |
| US-11440822-B2 | Methods and uses of dissolved organic material fractions for binding metal ions | Noblegen, Inc. (CA) | 2022-09-13 | — | — | US | disclosed |
| EP-3494093-B1 | METHODS AND USES OF DISSOLVED ORGANIC MATERIAL FRACTIONS FOR BINDING METAL IONS | NOBLEGEN INC (CA) | 2022-05-18 | — | — | EP | disclosed |
| US-20220128556-A1 | METHODS OF DIAGNOSING DISEASE | 4D Pharma Cork Limited (IE) | 2022-04-28 | — | — | US | disclosed |
| CN-114040986-A | Method of diagnosing disease | 4D制药科克有限公司 | 2022-02-11 | — | — | CN | disclosed |
| EP-3947743-A1 | METHODS OF DIAGNOSING DISEASE | 4D Pharma Cork Limited (IE) | 2022-02-09 | — | — | EP | disclosed |
| US-20200407252-A1 | METHODS AND USES OF DISSOLVED ORGANIC MATERIAL FRACTIONS FOR BINDING METAL IONS | TRENT UNIVERSITY (CA) | 2020-12-31 | — | — | US | disclosed |
| WO-2020201457-A1 | METHODS OF DIAGNOSING DISEASE | 4D Pharma Cork Limited (IE) | 2020-10-08 | — | — | WO | disclosed |
| US-10773978-B2 | Methods and uses of dissolved organic material fractions for binding metal ions | Noblegen, Inc. (CA) | 2020-09-15 | — | — | US | disclosed |
| US-20190210898-A1 | METHODS AND USES OF DISSOLVED ORGANIC MATERIAL FRACTIONS FOR BINDING METAL IONS | TRENT UNIVERSITY (CA) | 2019-07-11 | — | — | US | disclosed |
| EP-3494093-A1 | METHODS AND USES OF DISSOLVED ORGANIC MATERIAL FRACTIONS FOR BINDING METAL IONS | Noblegen Inc. (CA) | 2019-06-12 | — | — | EP | disclosed |
| US-9673030-B2 | Computer readable storage mediums, methods and systems for normalizing chemical profiles in biological or medical samples detected by mass spectrometry | EMORY UNIVERSITY (US) | 2017-06-06 | — | — | US | disclosed |
| EP-2279417-B1 | METABOLIC BIOMARKERS FOR OVARIAN CANCER AND METHODS OF USE THEREOF | GEORGIA TECH RES INST (US) | 2016-07-20 | — | — | EP | disclosed |
| US-20120004854-A1 | METABOLIC BIOMARKERS FOR OVARIAN CANCER AND METHODS OF USE THEREOF | GEORGIA TECH RESEARCH CORPORATION | 2012-01-05 | — | — | US | disclosed |
| US-20110282587-A1 | COMPUTER READABLE STORAGE MEDIUMS, METHODS AND SYSTEMS FOR NORMALIZING CHEMICAL PROFILES IN BIOLOGICAL OR MEDICAL SAMPLES DETECTED BY MASS SPECTROMETRY | EMORY UNIVERSITY (US) | 2011-11-17 | — | — | US | disclosed |
| EP-2279417-A1 | METABOLIC BIOMARKERS FOR OVARIAN CANCER AND METHODS OF USE THEREOF | Georgia Tech Research Corporation (US) | 2011-02-02 | — | — | EP | disclosed |
| WO-2009151967-A1 | METABOLIC BIOMARKERS FOR OVARIAN CANCER AND METHODS OF USE THEREOF | GEORGIA TECH RESEARCH CORPORATION (US) | 2009-12-17 | — | — | WO | disclosed |